Abstract
Background Since National Health Insurance (NHI) Program being launched on March 1, 1995 in Taiwan, rapid population ageing, dramatic increases in the number of patients suffering from catastrophic diseases, and the incessant introduction of new medical technologies, pharmaceutical products and devices ,NHI program has faced a serious financial deficit in recent years. The drug fees of NHI was about 4.4 billion USD in 2012, nearly 25% of total health insurance expenditure, and per capita was 204 USD. Over 16,000 drugs were listed in the Drug Fee Schedule, and the average growth rate on drug fees was 4.87% during 2000 to 2014. The price was adjusted 8 times from 2000 to 2013.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
